Express Scripts Holding Company (NASDAQ:ESRX) has received an average recommendation of “Hold” from the twenty-four brokerages that are presently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $70.57.
Several analysts recently commented on the company. ValuEngine downgraded Express Scripts Holding from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Mizuho dropped their price objective on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Needham & Company LLC assumed coverage on Express Scripts Holding in a research note on Friday, July 21st. They set a “hold” rating on the stock. Cowen and Company reaffirmed an “outperform” rating and set a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Finally, Evercore ISI dropped their price objective on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th.
Express Scripts Holding (NASDAQ:ESRX) traded up 0.904% on Friday, reaching $60.845. The company had a trading volume of 1,503,514 shares. The stock has a market capitalization of $35.14 billion, a price-to-earnings ratio of 10.560 and a beta of 0.90. Express Scripts Holding has a 12 month low of $57.80 and a 12 month high of $77.61. The firm has a 50 day moving average price of $62.85 and a 200-day moving average price of $64.55.
Express Scripts Holding (NASDAQ:ESRX) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.71 by $0.02. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same period last year, the company earned $1.57 EPS. The firm’s revenue was up .5% on a year-over-year basis. Analysts forecast that Express Scripts Holding will post $6.99 earnings per share for the current fiscal year.
In related news, VP Phyllis S. Anderson sold 1,100 shares of Express Scripts Holding stock in a transaction dated Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the completion of the transaction, the vice president now owns 11,108 shares in the company, valued at $667,368.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.68% of the stock is currently owned by insiders.
A number of institutional investors have recently bought and sold shares of the company. Burt Wealth Advisors boosted its position in Express Scripts Holding by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the last quarter. CKW Financial Group boosted its position in Express Scripts Holding by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares during the last quarter. Dubuque Bank & Trust Co. boosted its position in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares during the last quarter. TrimTabs Asset Management LLC acquired a new position in Express Scripts Holding during the first quarter worth approximately $121,000. Finally, Capital Analysts LLC boosted its position in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares during the last quarter. Institutional investors and hedge funds own 90.20% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was first reported by BNB Daily and is owned by of BNB Daily. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/brokerages-set-express-scripts-holding-company-nasdaqesrx-pt-at-70-18-updated-updated.html.
Express Scripts Holding Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.